Search

everythinglearnresearchcommunity

for

Search:↓

Over 40% of women have unwanted facial hair, which can affect their self-image, and should be managed with personalized treatment and support.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Timely diagnosis and active treatment improve outcomes for massive pulmonary embolism.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

Hair loss affects 20% of people, more in men and those over 35, and is often associated with a sensitive scalp.

A nonchemical lotion was found effective in killing head lice and their eggs in most people, indicating it could be useful for managing head lice.

Hair loss linked to prostate enlargement; stress and family history important factors.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Herbal medicines can be effective alternatives for treating hair loss.

Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

The review suggests seeing a dermatologist for scarring hair loss and using treatments like minoxidil or finasteride for common male and female pattern hair loss.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

The best concentration of triamcinolone acetonide for treating alopecia areata is still unclear.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Minoxidil response testing helps treat hair loss effectively and safely.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The woman's hair loss was mainly due to stress and low iron levels, and her hair grew back after treatment.

Behavioral therapy, N-acetyl cysteine, and olanzapine may help treat trichotillomania.

Alopecia areata affects self-esteem and social life, but new treatments offer hope.

Younger males with androgenic alopecia face significant psychological impacts but maintain better quality of life.